78
60
Growth Score 78 in past quarter
-11 pts
Heat Score 60 in past quarter
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
412269
Axela, Inc offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins.
About the Company
Axela offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. Our suite of products are specifically targeted at biomarker testing and infectious disease research and designed to facilitate the transition to personalized medicine. They are commercialized through
distributors in the Life Sciences and Clinical Research markets, and specific applications are licensed to diagnostic or industry segment partners. Our product line consists of instruments, consumable (sensors, chips and reagents) and applications (biomarker content, methods for analysis and software).